Cassava Sciences | PTIE - Market Capitalization


Cassava Sciences reported $86.1M in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Cara Therapeutics USD 28M 11M Dec/2024
Cassava Sciences USD 141M 54M Sep/2025
Eisai JPY 1.31T 140.95B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Geron USD 843M 31M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novavax USD 1.43B 340M Mar/2026
Pfizer USD 141.57B 6.48B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025